Privium Fund Management B.V.
Reported holdings as of Q2 2026, from 19 quarterly filings.
Holdings
| Security | Ticker | Value | Shares | Weight | Weight change | Held | Change |
|---|---|---|---|---|---|---|---|
| TESLA INC | TSLA | $95.9M | 228,000 | +0.44pp | 15q | +2.7%+$2.5M | |
| SHOPIFY INC | SHOP | $42.2M | 370,000 | -2.29pp | 19q | -9.1%-$4.2M | |
| ADVANCED MICRO DEVICES INC | AMD | $36.0M | 62,000 | +3.99pp | 4q | HELD | |
| AMAZON COM INC | AMZN | $33.4M | 140,000 | +0.71pp | 16q | +12.0%+$3.6M | |
| IONIS PHARMACEUTICALS INC | IONS | $25.4M | 319,924 | +0.13pp | 19q | +10.3%+$2.4M | |
| SPOTIFY TECHNOLOGY S A | SPOT | $25.3M | 55,000 | -2.12pp | 19q | -17.9%-$5.5M | |
| PALANTIR TECHNOLOGIES INC | PLTR | $23.3M | 200,000 | -1.80pp | 13q | HELD | |
| ARROWHEAD PHARMACEUTICALS IN | ARWR | $19.1M | 234,222 | -1.28pp | 19q | -36.2%-$10.8M | |
| OPENDOOR TECHNOLOGIES INC | OPEN | $18.2M | 3,940,904 | - | new | NEW | |
| LEMONADE INC | LMND | $17.6M | 270,259 | -0.10pp | 4q | +5.9%+$975.8K | |
| NVIDIA CORPORATION | NVDA | $16.2M | 81,000 | +0.04pp | 14q | HELD | |
| IREN LIMITED | IREN | $15.6M | 340,150 | +0.57pp | 4q | +6.2%+$914.6K | |
| UNIQURE NV | QURE | $15.1M | 328,322 | +1.12pp | 19q | -32.5%-$7.3M | |
| CEREBRAS SYSTEMS INC | CBRS | $13.4M | 60,500 | - | new | NEW | |
| AST SPACEMOBILE INC | ASTS | $12.9M | 145,000 | -0.13pp | 4q | HELD | |
| ULTRAGENYX PHARMACEUTICAL IN | RARE | $11.3M | 338,800 | +0.49pp | 19q | -7.1%-$868.2K | |
| ARCUTIS BIOTHERAPEUTICS INC | ARQT | $10.5M | 399,367 | +0.35pp | 7q | +24.4%+$2.1M | |
| BIOGEN INC | BIIB | $10.5M | 48,400 | +0.25pp | 5q | +10.5%+$993.9K | |
| PROQR THRAPEUTICS N V | PRQR | $10.3M | 5,520,024 | +0.04pp | 19q | +1.0%+$98.3K | |
| AXSOME THERAPEUTICS INC | AXSM | $9.8M | 39,944 | -0.27pp | 14q | -32.0%-$4.6M | |
| UROGEN PHARMA LTD | URGN | $7.7M | 210,000 | +0.53pp | 7q | -11.8%-$1.0M | |
| SPACE EXPLORATION TECHN CORP | SPCX | $6.8M | 40,000 | - | new | NEW | |
| DENALI THERAPEUTICS INC | DNLI | $5.9M | 229,857 | +0.07pp | 2q | -9.8%-$643.0K | |
| VERTEX PHARMACEUTICALS INC | VRTX | $4.7M | 9,400 | -0.20pp | 6q | -17.2%-$971.1K | |
| BIOMARIN PHARMACEUTICAL INC | BMRN | $4.3M | 75,000 | -0.30pp | 2q | -18.7%-$990.2K | |
| KRYSTAL BIOTECH INC | KRYS | $4.2M | 11,170 | +0.16pp | 18q | HELD | |
| ALNYLAM PHARMACEUTICALS INC | ALNY | $3.4M | 11,372 | -0.21pp | 2q | -7.0%-$255.9K | |
| VIRIDIAN THERAPEUTICS INC | VRDN | $3.2M | 173,516 | -0.12pp | 3q | HELD | |
| BIONTECH SE | BNTX | $2.8M | 30,100 | +0.02pp | 5q | +11.5%+$288.5K | |
| HIMS & HERS HEALTH INC | HIMS | $2.8M | 80,000 | +0.34pp | 5q | +100.0%+$1.4M | |
| MEIRAGTX HLDGS PLC | MGTX | $2.6M | 196,112 | +0.10pp | 10q | -7.5%-$216.2K | |
| AMBEV SA | ABEV | $2.5M | 802,167 | -0.11pp | 18q | -15.4%-$459.7K | |
| SAREPTA THERAPEUTICS INC | SRPT | $2.5M | 136,500 | +0.24pp | 3q | +196.7%+$1.6M | |
| CRISPR THERAPEUTICS AG | CRSP | $2.5M | 44,974 | +0.03pp | 14q | +4.9%+$114.5K | |
| BEAM THERAPEUTICS INC | BEAM | $2.4M | 70,282 | +0.13pp | 4q | +9.8%+$216.2K | |
| ZAI LAB LTD | ZLAB | $2.3M | 122,189 | -0.09pp | 19q | -7.6%-$190.0K | |
| MODERNA INC | MRNA | $2.1M | 29,994 | +0.07pp | 18q | HELD | |
| CARTESIAN THERAPEUTICS INC | RNAC | $1.6M | 151,675 | +0.06pp | 3q | -15.3%-$285.9K | |
| MAGNUM ICE CREAM CO NV | MICC | $1.5M | 98,221 | - | new | NEW | |
| WAVE LIFE SCIENCES LTD | WVE | $1.4M | 241,010 | -0.11pp | 8q | HELD | |
| TAYSHA GENE THERAPIES INC | TSHA | $1.4M | 198,900 | +0.08pp | 9q | +9.3%+$115.8K | |
| ZOETIS INC | ZTS | $1.2M | 17,322 | - | new | NEW | |
| 4D MOLECULAR THERAPEUTICS IN | FDMT | $1.2M | 90,110 | -0.11pp | 12q | -47.1%-$1.1M | |
| FATE THERAPEUTICS INC | FATE | $1.1M | 414,311 | +0.10pp | 8q | HELD | |
| LEGEND BIOTECH CORP | LEGN | $1.0M | 35,400 | - | new | NEW | |
| ROCKET PHARMACEUTICALS INC | RCKT | $835.0K | 244,146 | -0.03pp | 17q | +0.8%+$6.8K | |
| NOV INC | NOV | $779.6K | 42,026 | -0.02pp | 19q | HELD | |
| B2GOLD CORP | BTG | $729.6K | 195,083 | +0.04pp | 2q | +102.2%+$368.8K | |
| TOTALENERGIES SE | TTE | $729.5K | 10,723 | - | new | NEW | |
| LEXEO THERAPEUTICS INC | LXEO | $722.3K | 155,000 | -0.11pp | 7q | -24.4%-$233.0K | |
| TRANSOCEAN LTD | RIG | $712.0K | 145,604 | -0.02pp | 4q | +36.6%+$190.7K | |
| MOLINA HEALTHCARE INC | MOH | $681.3K | 2,979 | -0.10pp | 2q | -63.4%-$1.2M | |
| NU HLDGS LTD | NU | $587.8K | 44,000 | - | new | NEW | |
| AUTOLUS THERAPEUTICS LTD | AUTL | $581.5K | 363,430 | flat | 18q | HELD | |
| TIDEWATER INC NEW | TDW | $578.5K | 8,683 | +0.01pp | 5q | +58.4%+$213.2K | |
| LULULEMON ATHLETICA INC | LULU | $578.1K | 5,063 | - | new | NEW | |
| SANDRIDGE ENERGY INC | SD | $531.5K | 38,792 | -0.03pp | 9q | HELD | |
| SEABRIDGE GOLD INC | $425.0K | 16,512 | - | new | NEW | ||
| VOYAGER THERAPEUTICS INC | VYGR | $420.0K | 120,000 | -0.02pp | 6q | HELD | |
| Engene Therapeutics Inc | ENGN | $294.1K | 170,000 | - | new | NEW | |
| COSAN S A | CSAN | $149.8K | 52,000 | - | new | NEW |
By sector
Industry comes from the SIC code on each company's own SEC filings, which is self-reported and sometimes out of date. Derivative exposure is counted with the shares. Securities the SEC assigns no industry - funds, trusts, foreign issues - are shown as not classified rather than dropped.
| Sector | Value | Share |
|---|---|---|
| Biotech & Pharma | $174.2M | 32.0% |
| Autos & Aerospace | $95.9M | 17.6% |
| Software & IT Services | $65.6M | 12.1% |
| Semiconductors & Electronics | $52.2M | 9.6% |
| Telecom & Media | $38.1M | 7.0% |
| Retail & Consumer | $34.1M | 6.3% |
| Insurance | $18.3M | 3.4% |
| Real Estate | $18.2M | 3.3% |
| Banks & Lending | $16.1M | 3.0% |
| Other sectors | $10.8M | 2.0% |
| Not classified | $20.6M | 3.8% |
Quarter by quarter
| Quarter | Value | Positions | New | Added | Trimmed | Exited | Top 10 | Days to file |
|---|---|---|---|---|---|---|---|---|
| Q2 2026 | $544.2M | 61 | 12 | 18 | 18 | 11 | 61.8% | 38 |
| Q1 2026 | $480.3M | 60 | 7 | 24 | 17 | 4 | 64.0% | 35 |
| Q4 2025 | $543.1M | 57 | 6 | 24 | 15 | 8 | 68.2% | 34 |
| Q3 2025 | $556.3M | 59 | 8 | 20 | 16 | 4 | 74.8% | 35 |
| Q2 2025 | $463.5M | 55 | 7 | 23 | 7 | 8 | 81.5% | 30 |
| Q1 2025 | $383.6M | 56 | 5 | 20 | 13 | 13 | 77.1% | 39 |
| Q4 2024 | $441.9M | 64 | 10 | 24 | 14 | 28 | 74.2% | 42 |
| Q3 2024 | $402.0M | 82 | 12 | 36 | 11 | 59 | 65.7% | 32 |
| Q2 2024 | $392.1M | 129 | 22 | 36 | 34 | 10 | 60.2% | 32 |
| Q1 2024 | $374.5M | 117 | 17 | 43 | 23 | 14 | 58.2% | 30 |
| Q4 2023 | $359.0M | 114 | 18 | 27 | 28 | 19 | 58.3% | 57 |
| Q3 2023 | $336.2M | 115 | 17 | 25 | 27 | 26 | 59.3% | 37 |
| Q2 2023 | $347.4M | 124 | 27 | 26 | 29 | 29 | 55.5% | 26 |
| Q1 2023 | $297.7M | 126 | 24 | 30 | 40 | 48 | 55.0% | 33 |
| Q4 2022 | $263.7M | 150 | 28 | 36 | 41 | 88 | 54.8% | 34 |
| Q3 2022 | $275.2M | 210 | 36 | 27 | 69 | 71 | 48.6% | 34 |
| Q2 2022 | $301.8M | 245 | 32 | 48 | 64 | 62 | 49.8% | 28 |
| Q1 2022 | $452.4M | 275 | 64 | 73 | 32 | 41 | 48.4% | 40 |
| Q4 2021 | $504.3M | 252 | 0 | 0 | 0 | 0 | 54.1% | 40 |
Rows marked UNVERIFIED ID, PLACEHOLDER ID, TICKER AS ID or NON-CUSIP ID carry an identifier that is not a valid CUSIP. They are shown because the filer reported that money, but treat the security named with caution - hover the chip for what is wrong with it, and see the methodology.
Held counts consecutive filings in which this manager reported the position, and can reach further back than the quarters listed above: the tabs begin at Q4 2018 because earlier coverage is too sparse to describe a market, but tenure is counted over every filing we hold, some reaching to 2007. A position sold and later rebought starts again from one.
Weight change is the shift in this position's share of the whole book, in percentage points. It is the more useful column: when money flows into or out of a broad fund, almost every holding is bought or sold at once, so added and trimmed largely track flows. A weight that rose while the book shrank is a decision. Both compare with the previous quarter this filer reported, not the previous calendar quarter.